Company

Bambusa Therapeutics

Industryclinical-stage biotechnology company advancing bispecific antibodies for immunology and inflammation (I&I)

Funding raised

CompanyRoundDate
Bambusa TherapeuticsSeries A2025-11-17
Bambusa TherapeuticsSeries Seed Funding2024-09-09